References
- Kinget R, Van Roelen R. The absorption of 8-methoxy-psoralen from lipid-containing semisolid matrices for oral use: a prospective study in rabbits. J Dermatol Treat 1994; 5: 25–8
- Roelandts R, Van Boven M, Deheyn T, et al. Dietary influences on 8-MOP plasma levels in PUVA patients with psoriasis. Br J Dermatol 1981; 105: 569–72
- Roelandts R. Analysing the photochemotherapeutical principle in the treatment of psoriasis. Leuven University Press, Leuven 1990
- Nitsche V, Raff M, Bardach H. 8-Methoxypsoralen (8-MOP) in neuer galenischer Zubereitung und seine Beziehung zum 8-MOP-Serumspiegel. Arch Dermatol Res 1981; 271: 11–17
- Andersen K E, Menne T, Gammeltoft M, et al. Pharmaco-kinetic and clinical comparison of two 8-methoxypsoralen brands. Arch Dermatol 1980; 268: 23–9
- Beani J C, Bonnot D, Berthod F, et al. Bioavailability of two 8-methoxypsoralen formulations. J Dermatol Treat 1992; 3: 129–32
- Monbaliu J G, Belpaire F M, Bogaert M G. Study of the bioavailability of different formulations of 8-methoxypsoralen in the dog. Biopharm Drug Dispos 1988; 9: 1–8
- Parrish J A, Chylack L Y, Woehler M E, et al. Dermatological and ocular examinations in rabbits chronically photosensitized with methoxalen. J Invest Dermatol 1979; 73: 256–8
- Stolk L ML. Farmacokinetische en biofarmaceutische aspecten van enige in de dermatologie gebruikte psorale-enderivaten. Universiteit van Amsterdam, Amsterdam 1982, PhD thesis
- Bonnot D, Beani J C, Boitard M. Importance de la determination de la cinétique plasmatique du méthoxy-8-psoralène dans le traitement du psoriasis par PUVA thérapie. J Pharm Clin 1987; 6: 309–26